Q Bio is creating technology aimed at revolutionizing primary care through advanced health measurement solutions. Their flagship product, the clinical digital twin platform, Gemini, utilizes whole-body scanning technology to capture and monitor an individual's physiological data. This platform enables the visualization and sharing of critical health changes, considering a person's lifestyle, genetics, and medical history, which can be communicated securely with healthcare providers globally. The Gemini system is powered by the Mark I scanner, designed for rapid and comfortable scanning in less than 15 minutes without the need for radiation. Founded in 2015, Q Bio is driven by a mission to enhance proactive healthcare and is supported by a diverse team of engineers and scientists dedicated to innovation and collaboration in the healthcare space. The company places a strong emphasis on growth and empowerment within its workforce, creating an environment conducive to both professional development and impactful contributions to patient care.